Şunu aradınız:: then experience disease progression (İngilizce - Slovakça)

disease progression
progresia choroby

disease progression b n (%)
progresia ochoreniab n (%)

disease progression and overall survival
progresia ochorenia a celkové prežívanie

week 25 onwards until disease progression
od 25. týždňa do progresie ochorenia

time to disease progression, median months
Čas do progresie ochorenia, medián v mesiacoch

patients were treated until disease progression.
pacienti boli liečení až do progresie ochorenia.

all treatments were continued until disease progression.
všetky druhy liečby pokračovali až do progresie ochorenia.

treatment continued until patients had disease progression.
liečba pokračovala až do progresie ochorenia pacientov.

disease progression; unsatisfactory long-term clinical response.
progresia ochorenia, neuspokojivá dlhodobá klinická odpoveď na liečbu.

*patients may have had multiple sites of disease progression
0, 986 0, 250 0, 004 0, 915 0, 643 0, 667 0, 377 0, 410

idelalisib was taken until disease progression or unacceptable toxicity.
idelalisib sa užíval až do progresie ochorenia alebo do neprijateľnej toxicity.

in both studies, treatment was to continue until disease progression.
v oboch štúdiách sa s liečbou pokračovalo až do progresie ochorenia.

metastatic disease progression was inhibited and microvascular permeability was reduced.
progresia metastatickej choroby bola inhibovaná a mikrovaskulárna permeabilita sa znížila.

2), and type of disease progression (psa only vs. radiographic).
2) a typu progresie ochorenia (iba psa vs. rádiografická).

patients were treated with pembrolizumab until disease progression or unacceptable toxicity.
pacienti sa liečili pembrolizumabom až dovtedy, kým nedošlo k progresii ochorenia alebo k neakceptovateľnej toxicite.

treatment for all patients continued until disease progression, death or withdrawal.
u všetkých pacientov liečba pokračovala až do progresie ochorenia, úmrtia alebo predčasného ukončenia štúdie.

avastin 10 mg/kg was given every 2 weeks until disease progression.
avastin 10 mg/kg bol podávaný raz za 2 týždne až do progresie ochorenia.

6 time to disease progression: interval from the first infusion to disease progression.
nepotvrdená kompletná odozva 3 odhad so sledovaným rozsahom 4 trvanie odozvy: interval od počiatku odozvy do progresie choroby 5 “ + ” označuje prebiehajúcu odozvu 6 doba do progresie choroby: interval od prvej infúzie do progresie choroby

the inclusion criteria identified patients who at baseline had evidence of early disease progression.
podľa kritérií pre zaradenie sa identifikovali pacienti, u ktorých sa na začiatku skúšania preukázalo skoré štádium ochorenia.

tarceva or placebo was taken orally once daily until disease progression or unacceptable toxicity.
tarceva alebo placebo sa užívali perorálne jedenkrát denne až do progresie ochorenia alebo neakceptovateľnej toxicity.